Tag Archives: Neil Bodick

Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More

If you’re keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there’s Sarepta Therapeutics. Late Thursday, the FDA announced approval of the Cambridge, MA, biotech’s drug for Duchenne muscular dystrophy in patients who have a specific mutation. The […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Europe blog main, Europe top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More

Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs

(Corrected, 2/12/14 at 12:11 pm ET) Flexion Therapeutics today became the latest biotech to jump into the IPO queue, looking to public investors to help bankroll the development of its osteoarthritis drugs. The Burlington, MA-based company filed its IPO prospectus with the Securities and Exchange Commission late Wednesday, outlining plans to raise as much as […]

Posted in Boston, Boston blog main, Boston top stories, National blog main | Tagged , , , , , , , , , , , , , , | 2 Comments

Flexion Overhaul Bears Fruit With Upbeat Data From Arthritis Trial

[Updated 5/30/12 8:30 am. See below.] Today Woburn, MA-based Flexion Therapeutics announced that its treatment for osteoarthritis met its goal of significantly relieving joint pain in a mid-stage trial. Even though it’s a bit early to declare the drug a success, the results come as welcome news to the executives of Flexion, who have spent […]

Posted in Boston, Boston blog main, National blog main | Tagged , , , , , , , , , , , , , | 1 Comment

Flexion Snags Pfizer Bucks, Three Pharma Deals, For New Drug Model

Flexion Therapeutics is a little company built on the idea it can steer through early clinical trials in a faster and cheaper way than a lumbering Big Pharma giant. Now the Woburn, MA-based startup, founded by a pair of Eli Lilly veterans, has secured backing from four major drugmakers to put the idea to the […]

Posted in Boston, Boston blog main, National blog main | Tagged , , , , , , , , , , , , | 7 Comments

Flexion Therapeutics Gets $33M For Faster, Cheaper Drug Development

[Update: 10/16/09, 3:18 pm Eastern] Flexion Therapeutics, the Woburn, MA-based company that seeks to reduce the time and expense of drug development’s risky early steps, has raised $33 million in a Series A venture round, according to a statement. Earlier in the day, we reported the deal was for $20 million, out of a potential […]

Posted in Boston, Boston blog main, National blog main | Tagged , , , , , , , , , , , , , , | Comments Off on Flexion Therapeutics Gets $33M For Faster, Cheaper Drug Development